[144] Sempra SEC Filing

Rhea-AI Filing Summary

Sempra (SRE) Form 144 notice: An insider filed a proposed sale of 5,114 shares of Sempra common stock through Oppenheimer & Co., with an aggregate market value of $420,473.08 and approximately 652,472,426 shares outstanding. The sale is listed with an approximate date of 08/14/2025 on the NYSE.

The 5,114 shares being offered match recent equity compensation events: restricted stock units vested on 01/02/2025 (4,176 shares) and 01/28/2025 (711 shares), plus reinvested dividends on 01/15/2025 (32), 04/15/2025 (100) and 07/15/2025 (95). No securities were reported sold by this person in the past three months. The filer affirms no undisclosed material adverse information.

Positive

• Full provenance disclosed: All 5,114 shares are traced to RSU vesting and dividend reinvestment, supporting transparency
• No recent sales by the filer in the past three months, reducing concerns about accelerated insider unloading

Negative

• Insider sale planned of 5,114 shares (though small versus outstanding shares), which some investors may view negatively
• Aggregate value $420,473.08 could attract attention despite being a minor portion of total market capitalization

Insights

Securities Analyst

TL;DR: Small, routine insider sale tied to vesting and dividend reinvestment; unlikely to be materially market-moving.

The filing documents a proposed sale of 5,114 shares valued at $420k, originating from recent restricted stock unit vestings and dividend reinvestments. The sale uses a broker and is scheduled for a single approximate date. Given Sempra's outstanding share base of ~652 million, the position represents a de minimis fraction of float and appears to be a liquidity event following compensation vesting rather than a signal of company-specific deterioration. The absence of prior sales in the past three months and the filer’s attestation reduce indicators of immediate governance or disclosure concerns.

Corporate Governance Specialist

TL;DR: Compliance-oriented disclosure of compensation-related share disposal; standard Form 144 mechanics observed.

The notice details the provenance of the shares—RSU vesting and dividend reinvestment under the company’s long-term incentive plan—fulfilling Rule 144 disclosure norms. Use of an established broker and the filer’s certification regarding material information align with routine compliance practice. No unusual payment terms or aggregated sales are reported. From a governance perspective, this is a typical post-vesting liquidity action with limited apparent governance risk.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Oppenheimer & Co., Inc. 10880 Wilshire Boulevard Los Angeles CA 90024	5114	420473.08	652472426	08/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/02/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			4176	01/02/2025	Vesting of equity award received as compensation
Common Stock	01/15/2025	Reinvested dividends from certain vested restricted stock units	Sempra			32	01/15/2025	Vesting of equity award received as compensation
Common Stock	01/28/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			711	01/28/2025	Vesting of equity award received as compensation
Common Stock	04/15/2025	Reinvested dividends from certain vested restricted stock units	Sempra			100	04/15/2025	Vesting of equity award received as compensation
Common Stock	07/15/2025	Reinvested dividends from certain vested restricted stock units	Sempra			95	07/15/2025	Vesting of equity award received as compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares of Sempra (SRE) are being offered in this Form 144?

The filer proposes to sell 5,114 shares of Sempra common stock.

What is the aggregate market value of the proposed sale?

The aggregate market value reported is $420,473.08.

When is the approximate date of the proposed sale?

The Form 144 lists an approximate sale date of 08/14/2025.

How were the shares acquired by the filer?

Shares were acquired through vesting of restricted stock units under Sempra's long-term incentive plan and reinvested dividends on specified dates in 2025.

Which broker is handling the proposed sale?

The broker named in the filing is Oppenheimer & Co., Inc.

Did the filer report any sales of the issuer's securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.